# Xolair in Patients With Chronic Sinusitis

> **NCT00117611** · PHASE4 · COMPLETED · sponsor: **University of Chicago** · enrollment: 14 (actual)

## Conditions studied

- Sinusitis

## Interventions

- **DRUG:** Anti-IgE antibody omalizumab or placebo

## Key facts

- **NCT ID:** NCT00117611
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-05
- **Final completion:** 2009-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2013-09-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00117611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00117611, "Xolair in Patients With Chronic Sinusitis". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00117611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*